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A Novel Role for FAK as a Protease-Targeting
Adaptor Protein: Regulation by p42 ERK and Src
sis of FAK and focal-adhesion turnover [11, 15]. To probe
the mechanism by which Src and FAK promote focal-
adhesion turnover during transformation and migration,
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kd can readily associate with Calpain 2 and that assem-
bly of the Calpain 2/FAK/p42ERK complex occurs to a
similar extent as in FAK-wt cells (Figure 1B, lane 4 andSummary
densitometry data, Figure S1 in the supplemental data
available with this article online). This data indicates thatCell migration on extracellular matrix requires the
FAK’s kinase activity is not required for the assemblyturnover of integrin-dependent adhesions. The nonre-
of the Calpain 2/FAK/p42ERK complex.ceptor tyrosine kinases Src and FAK regulate focal-
To further address the determinants of assembly ofadhesion turnover by poorly understood mechanisms
the Calpain 2/FAK/p42ERK complex, we expressed a mu-[1, 2, 3]. ERK/MAP kinase-mediated activation of the
tant FAK in which the amino-terminal proline-rich se-protease Calpain 2 also promotes focal-adhesion turn-
quence at residues 368–378 was mutated (FAK-Pro2);over [4, 5, 6]; however, it is not known if this is linked to
alanine (A) was substituted for critical prolines (RALASIA)the activities of Src and FAK. Calpain 2 has previously
[16]. Expression of the FAK-Pro2 mutant inhibited coim-been demonstrated to colocalize with focal-adhesion
munoprecipitation of both FAK and p42ERK with Cal-structures [7] and can cleave several focal-adhesion
pain 2 (Figure 1C, lane 4). Analysis of complex formationcomplex components, including FAK [8–13]. Studies
utilizing Calpain inhibitors or Calpain-deficient cells in cells expressing FAK-Pro2 was carried out in parallel
confirm that Calpain’s role in regulating focal-adhe- with that of cells expressing FAK-wt (Figure 1C, lanes
sion turnover is necessary for cell migration [10, 11, 1 and 2).
14]. We have identified a novel and kinase-indepen- The absence of p42ERK from Calpain 2 immunopre-
dent function for FAK as an adaptor molecule that cipitates in cells expressing FAK-Pro2 implies that the
mediates the assembly of a complex consisting of at association of p42ERK with Calpain 2 requires FAK as
least Calpain 2 and p42ERK. Mutation of proline resi- an intermediate. This adaptor function of FAK is critical
dues (Pro2) in the amino-terminal region of FAK blocks for formation of a protein complex containing the prote-
direct binding with Calpain 2 and also prevents forma- ase Calpain 2 and its upstream activator p42ERK. To
tion of the Calpain 2/p42ERK complex in cells. We demonstrate that Calpain 2 directly binds with FAK and
show that both complex formation and MEK/ERK activ- that mutation of the Pro2 site abolishes this binding, we
ity are associated with Calpain-mediated proteolysis of have performed far-Western blot analysis. In contrast
FAK and focal adhesion turnover during transformation to immunoprecipitated FAK-wt, recombinant Calpain 2
and migration. Furthermore, FAK is necessary for re-
does not directly associate with immunoprecipitatedcruiting both Calpain 2 and p42ERK/MAPK to peripheral
FAK-Pro2 (Figure 2A, on left). Equal levels of immuno-adhesion sites facilitating maximal Calpain activity.
preciptated FAK-wt and FAK-Pro2 were separated by
SDS-PAGE as determined by immunoblotting with anti-Results and Discussion
FAK (Figure 2A, on right). These data suggest that muta-
tion of the Pro2 site on FAK abolishes its direct interac-FAK and p42ERK/MAP Kinase Physically Complex
tion with Calpain 2. In addition to exogenous myc-FAK,with Calpain 2 in Src-Transformed Cells
we also show that endogenous FAK and p42 ERK wereWe have previously demonstrated that activation of the
present in anti-Calpain 2 immunoprecipitates (Figurev-Src oncoprotein induces Calpain-mediated proteoly-
2B), demonstrating that formation of the complex does
not require FAK overexpression such as we used in the*Correspondence: n.carragher@beatson.gla.ac.uk (N.O.C.); m.frame@
beatson.gla.ac.uk (M.C.F.) FAK mutant analysis above.
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Figure 1. Calpain 2 Forms a Complex with FAK and Phospho-ERK
(A) myc-tagged wild-type FAK (FAK-wt) was immunoprecipitated (IP) from CEFs. Anti-myc IP’s were separated by SDS-PAGE and immunoblot-
ted with an antibody against Calpain 2. Control IP reactions were performed with nonspecific anti-mouse IgG (mIgG). The molecular weight
of coimmunoprecipitating Calpain 2 was compared with purified Calpain 2 (-).
(B) Total cell lysates were prepared, and Calpain 2 was immunoprecipitated from CEFs coexpressing ts LA29 v-Src with either myc-tagged
FAK-wt or kinase-defective FAK (FAK-kd) after culture at restrictive (-) and 24 hours at permissive () temperatures for v-Src activation.
Calpain 2 association with exogenously expressed FAK and active p42ERK in these cells was detected by SDS-PAGE and immunoblotting
with anti-phospho-p42ERK and -myc. Direct Western blots of the same total cell lysates used for immunoprecipitation experiments are shown
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Figure 2. Calpain 2 Directly Interacts with Wild-Type FAK
(A) Wild-type (wt) and Pro2 FAK mutant (myc tagged) were immunoprecipitated from CEFs with anti-myc, separated by SDS-PAGE and
incubated with recombinant Calpain 2. Calpain 2 associated with FAK-wt and FAK pro2 was detected by subsequent immunoblotting with
anti-Calpain 2. Control IP reactions from FAK-wt expressing cells were performed with non-specific anti-mouse IgG (mIgG). Equal levels of
immunoprecipitated FAK-wt and FAK-Pro2 were determined by immunoblotting with anti-FAK (on right).
(B) Calpain 2 IP’s from CEFs expressing only endogenous FAK also demonstrate v-Src-induced association among Calpain 2, endogenous
FAK, and p42ERK. Control IP’s with nonspecific anti-rabbit IgG (rIgG) are shown. In these experiments we have used a phospho-specific
antibody against p42ERK to monitor both the binding of ERK and its activation state within the complex. Total protein levels in cell lysates
are shown on the right. Detailed methods of all techniques can be found in the Supplemental Data.
The Amino-Terminal Proline Sequence ing an ideal model system for studying the biological
consequences of the Calpain 2/FAK/p42ERK complex.Is Required for FAK Degradation,
Focal Adhesion Turnover, and Cell Migration To determine whether formation of the Calpain 2/FAK/
p42ERK complex was required for Calpain-mediatedTransformation induced by v-Src in primary embryo fi-
broblasts (but not in established cell lines) induces an proteolysis of FAK, we monitored the stability of wild-
type FAK(-wt) and FAK-Pro2 in transformed cells, inextreme transformed phenotype whereby the normal
balance of focal adhesion assembly and disassembly which focal adhesions are turning over rapidly. Consis-
tent with the degradation of endogenous FAK that weis dramatically skewed toward complete disassembly,
cell rounding, and detachment. This extreme phenotype have previously reported [11, 17], exogenous FAK-wt
levels were decreased by 3 hr after v-Src activation, andinduced by strongly transforming v-Src allows us to
monitor the mechanisms controlling Calpain-dependent FAK-wt was not detectable in fully transformed cells at
24 hr (Figure 3A, upper panel). In contrast, the FAK-Pro2proteolysis of FAK and focal adhesion turnover, provid-
below and demonstrate degradation of FAK in Src-transformed cells, as previously described [11, 17].
(C) Nontransformed and v-Src-transformed CEFs expressing either wild-type (wt) or Pro2 FAK mutant (myc tagged) were developed as
described above. Total cell lysates were prepared, and Calpain 2 was immunoprecipitated. Calpain 2-associated active phosphorylated
p42ERK (phospho-p42ERK) and exogenous FAK were detected after SDS-PAGE, transfer to membrane, and immunoblotting. Direct Western
blots of the same total cell lysates used for immunoprecipitation experiments are shown below.
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Figure 3. FAK Pro2 Sequence Is Necessary
for FAK Degradation and Focal Adhesion
Turnover
(A) Cell lysates were prepared at sequential
time points after v-Src activation from CEFs
coexpressing ts v-Src with myc-tagged wild-
type FAK, pro2 FAK, and kinase-defective
(kd) FAK. Protein levels of wild-type FAK,
Pro2 FAK, and kd FAK were detected by SDS-
PAGE and immunoblotting with anti-myc an-
tibody. Protein loading was analysed by im-
munoblotting with anti--tubulin antibody.
(B) myc-tagged wild-type FAK and Pro2 FAK
mutant retain the ability to target to focal ad-
hesion sites in nontransformed cells (v-Src
off), as determined by immunostaining with
anti-myc antibody. Focal adhesion structures
and cell morphology of CEFs expressing Pro2
FAK are not significantly altered under normal
conditions (v-Src off) when these cells are
compared with cells expressing wild-type
FAK. However, upon v-Src activation, wild-
type FAK redistributes from focal adhesion
sites to a more-diffuse cytoplasmic staining
pattern, and cells undergo morphological
transformation. In contrast, the Pro2 FAK mu-
tant is retained within focal adhesions at the
cell periphery, and Src-induced focal adhe-
sion disassembly and morphological trans-
formation are impaired.
(C) CEFs coexpressing ts v-Src with either
wild-type FAK or Pro2 FAK mutant were ana-
lyzed for their ability to invade a wounded
monolayer 12 hr after v-Src activation.
mutant protein that impaired formation of the Calpain between cells expressing FAK-wt or FAK-Pro2 proteins
(both FAK-wt and FAK-Pro2 proteins localized to focal2/FAK/ERK complex was relatively stable after v-Src
activation (Figure 3A, middle panel). A kinase-defective adhesions normally in nontransformed cells). Six hours
after v-Src activation (v-Src on), cells expressing FAK-FAK (FAK-kd) is degraded to a similar extent as FAK-
wt, indicating that the kinase activity of FAK is not re- wt underwent morphological transformation with few
residual focal adhesions. In contrast, FAK-Pro2 mutantquired for FAK degradation (Figure 3A, lower panel).
Because we have previously shown that v-Src-induced proteins remained in peripheral focal adhesions after
v-Src activation, and morphological transformation wasproteolytic cleavage of FAK was mediated by Calpain
2 [11, 15], the above results imply that v-Src-induced prevented in these short-term transformation assays
(Figure 3B; similar staining was observed with an anti-formation of the Calpain 2/FAK/p42ERK complex is re-
quired for Calpain 2-mediated proteolysis of FAK. vinculin antibody; results not shown).
In addition to morphological transformation, we alsoTo examine the biological consequences of express-
ing myc-tagged FAK-wt or FAK-Pro2 mutants in normal monitored cell migration by wound repair assays. We
found that cells coexpressing ts v-Src with FAK-wt wereor transformed cells, we examined adherent cells by
immunofluorescence and confocal microscopy by using efficiently able to migrate into the denuded area of cell
monolayers as transformed cells (Figure 3C). In contrast,an anti-myc antibody to detect exogenous FAK protein
(Figure 3B). In nontransformed cells (v-Src off), cell mor- cells coexpressing ts v-Src and FAK-Pro2 were impaired
in their ability to migrate (Figure 3C). Overexpressionphology and distribution of focal adhesions were similar
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Figure 4. ERK/MAP Kinase Activity Is Required for Src-Induced FAK Proteolysis and Focal Adhesion Turnover
Cell transformation was initiated by v-Src activation in the absence (-) or presence () of (A) MEK inhibitor (UO126, 50 M) or (B) the N-terminal
dominant-negative MEK1 peptide (MEK1-N, 100 M). Cell lysates were separated by SDS-PAGE and immunoblotted with antibodies against
total and active (phospho) p42ERK and FAK. Cells expressing ts v-Src were preincubated with UO126 or MEK1-N 1 hr prior to v-Src activation,
then for 24 hr after v-Src activation. (C) Calpain 2 was immunoprecipitated from transformed cells ( v-Src activation) in the absence (-) or
presence () of UO126 (50 M). Calpain 2-associated, total and active (phospho) p42ERK and FAK was determined by SDS-PAGE and
immunoblotting with specific antibodies. (D) v-Src-transformed cells were incubated in the absence (control) or presence of UO126 (50 M)
or MEK1-N (100 M). Cell morphology and focal adhesion structures were analyzed by immunostaining with anti-vinculin antibody.
of kinase-defective FAK did not impair morphological ERK/MAPK Activity Is Required for FAK
Proteolysis, Transformation, and Migrationtransformation or cell migration of CEFs after v-Src acti-
vation (results not shown), further indicating that FAK Because p42ERK/MAP kinase is recruited to the Calpain
2/FAK/p42ERK complex, we addressed whether activityregulates these events in primary fibroblasts via its pro-
tein adaptor function. Together with our previous data of MEK1/ERK is required for effective proteolysis of FAK
and focal adhesion turnover. Cells were treated withshowing that Calpain inhibition suppresses v-Src-trans-
formed cell migration [11], our results imply that assem- the MEK inhibitor U0126 (50 M) [18] or the dominant-
negative MEK1 N-terminal peptide (MEK1-N, 100 M)bly of the Calpain 2/FAK/p42ERK complex is required
for Calpain 2-mediated proteolysis of FAK and focal [19]. Treatment with UO126 or MEK1-N effectively inhib-
ited activation of p42ERK after v-Src activation, asadhesion turnover during cell migration and Src-medi-
ated transformation. shown by immunoblotting with an antibody against the
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Figure 5. Pyk2 Substitutes for FAK in Calpain 2-ERK/MAPK Complex
Cell lysates were prepared, and Calpain 2 was immunoprecipitated from wild-type, FAK knock-out (FAK/), and Src, Yes, Fyn knock-out
(SYF/) MEFs. Cell lysates and Calpain 2 IP’s were separated by SDS-PAGE, transferred to membrane, and immunoblotted with antibodies
against active ERK (phospho-p42ERK), FAK, Pyk2, Src, and Calpain 2. We confirmed that none of the Calpain 2 coimmunoprecipitating
proteins (ERK, FAK, Src, and Pyk2) were present in normal rabbit IgG control immunoprecipitations from MEFs. Total protein levels were
monitored in cell lysates by direct Western blot on the right.
phosphorylated activated form of p42ERK (phospho- gesting that although Src was present in the complex,
ubiquitous Src family kinases were not required for as-p42ERK) (Figures 4A and 4B). However, inhibition of ERK
activation by UO126 did not stop the Calpain 2/FAK/ sembly. In addition, Calpain 2 and p42ERK coimmuno-
precipitated from FAK/ MEFs (Figure 5). This wasERK complex from forming (Figure 4C). Both UO126 and
MEK1-N treatment suppressed the proteolytic degrada- surprising because our experiments in cells that overex-
pressed the FAK-Pro2 mutant implied that FAK’s adap-tion of FAK (Figures 4A and 4B) and focal adhesion
disassembly during v-Src-induced transformation (Fig- tor function was important for formation of the complex
(Figure 1C). However, an explanation was provided byure 4D). In addition, UO126 and MEK1-N treatment sub-
stantially reduced Calpain activity as early as 6 hr after the apparent replacement of FAK with the homologous
protein, Pyk2, in the Calpain 2 complex in FAK/ cellsv-Src activation (data are shown in Figures S2A and S2B
in the supplemental data) and suppressed migration of (Figure 5). As previously reported, we found that Pyk2
was substantially upregulated in FAK/ cells ([21]; Fig-both normal and Src-transformed cells in wound repair
assays (data are shown in Figures S3A and S3B). These ure 5, right panels). Interestingly, although mutation of
the amino-terminal proline sequence (Pro2) of FAK in-results indicate that ERK (p42ERK in the case of chicken
embryo fibroblasts used here), which is recruited into hibited association with Calpain 2 (Figure 1C), this se-
quence is not conserved in Pyk 2, suggesting that thethe Calpain 2/FAK complex (Figures 1 and 2) and to
focal adhesion sites after v-Src activation [20], is needed FAK Pro2 sequence may perform functions other than
making direct contacts with Calpain 2. Such functionsfor Calpain 2-dependent proteolysis of FAK and focal
adhesion turnover. might include maintaining conformation to allow other
sequences in FAK to bind to cellular partners, including
Calpain 2.FAK Targets Calpain 2 and ERK/MAPK
to Peripheral Focal Adhesion Sites As shown, Pyk2 can compensate for FAK’s adaptor
function in assembly of the Calpain 2/FAK/p42ERK com-To further define the role of endogenous Src family
kinases (SFKs) and FAK in assembly of the Calpain plex in FAK/ cells, yet focal adhesion turnover and
migration is impaired in these cells [1]. This indicates2/p42ERK complex, we immunoprecipitated Calpain 2
from normal mouse embryo fibroblasts (MEFs) or from that Pyk2 cannot compensate for FAK function in induc-
ing focal adhesion turnover and cell migration. Reason-MEFs that were null for all three of the ubiquitous SFKs
(Src, Yes, and Fyn; [SYF/]) or for FAK (FAK/). We ing that Pyk 2 differs from FAK by having a less-efficient
focal adhesion targeting sequence and is unable to locatefound that Calpain 2 coimmunoprecipitated with endog-
enous FAK and p42ERK in normal MEFs and that some to focal adhesions in FAK/ cells [21], we addressed
whether localization of Calpain 2 or ERK was impairedendogenous Src was also present in the complex (Figure
5). Furthermore, Calpain 2 and p42ERK coimmunopreci- when Pyk2 replaced FAK in the Calpain 2/FAK-Pyk2/
p42ERK complex. We found that Calpain 2 partially colo-pitated equally well from SYF/ MEFs (Figure 5), sug-
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Figure 6. FAK Targets Calpain 2 and ERK/MAPK to Peripheral Focal-Adhesion Sites
(A) Wild-type (FAK/) and FAK/ cells were dual-labeled by immunostaining with antibodies against Calpain 2 and paxillin. Cells were also
immunostained with an antibody against active phosphorylated ERK (phospho-ERK). All cells were examined by confocal microscopy. Arrows
indicate localized Calpain 2 and phospho-ERK staining. The scale bars represent 25 m.
(B) FAK/ cells subjected to transient reexpression of myc-tagged wild-type FAK were coimmunostained with either anti-myc and anti-
Calpain 2 antibodies or anti-myc and anti-phospho-ERK antibodies. Arrows indicate cells expressing FAK and localized Calpain 2 and p42ERK
immunostaining. The scale bars represent 25 m.
(C) Calpain activity was visualized in wild-type and FAK/ MEFs by incubation of cells with the cell-permeable fluorogenic Calpain substrate
BOC-LM-CMAC (Molecular probes Inc.) and analysis by confocal microscopy (X630 magnification). The scale bars represent 25 m.
calized with paxillin at the cell periphery of wild-type evident in FAK/ cells, with Calpain 2 in these cells
being diffusely localized throughout the cytoplasm (Fig-MEFs (FAK/ cells), the pattern of staining indicating
that Calpain 2 was present in a subset of discrete focal ure 6A). Similarly, antibodies recognizing the activated
form of ERK (phospho-ERK) demonstrate a diffuse stain-adhesion regions (Figure 6A, merged images). However,
Calpain 2 colocalization with focal adhesions was not ing pattern in FAK/ cells, whereas there was some
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